Belay Diagnostics
About Belay Diagnostics
The startup develops a cerebrospinal fluid assay that utilizes cytology to detect aneuploidy, mutations, and methylation, enabling the identification of cancer cells and other abnormalities. This technology facilitates earlier and more accurate cancer diagnoses, improving patient outcomes through timely intervention.
What does Belay Diagnostics do?
The startup develops a cerebrospinal fluid assay that utilizes cytology to detect aneuploidy, mutations, and methylation, enabling the identification of cancer cells and other abnormalities. This technology facilitates earlier and more accurate cancer diagnoses, improving patient outcomes through timely intervention.
Where is Belay Diagnostics located?
Belay Diagnostics is based in Chicago, United States.
When was Belay Diagnostics founded?
Belay Diagnostics was founded in 2022.
How much funding has Belay Diagnostics raised?
Belay Diagnostics has raised 5750000.
- Location
- Chicago, United States
- Founded
- 2022
- Funding
- 5750000
- Employees
- 35 employees